Search results for: Multi-Indication Medicines

Around The World in HTAs: The Netherlands – 5 Routes for New Tech

24 May 2023

…Medicines Evaluation Board (MEB). In doing so, the MEB primarily looks at the balance between efficacy and risks; Procedures to become eligible for reimbursement within the framework of the insured…

OHE at IHEA 2023

9 July 2023, 7:00am

…Session Room 1.63- 1.64 Graham Cookson 10/07/2023 10:00-12:00 SAST / 09:00-11:00 BST Proposed Price Regulations for Patented Medicines in Canada Organised Session Clivia Conservatory Sian Besley 10/07/2023 15:00-15:30 SAST /…

Reimagining Prevention for a Healthier, More Prosperous Society

29 November 2023, 3:00pm

…industry. He is passionate about delivering transformational, industry-leading clinical change and securing patient access to lifesaving medicines through effective medical affairs. He also has over 4 years of experience as…

Dilek Sernur Eminoğulları

26 January 2024

…Her main interest areas include health technology assessment models, rare disease policies, innovative contracting models, the use of real world data in reimbursement, patient access to medicines, e-health and vaccination…

Prof. John Cairns

8 March 2024

…since 2020. He has previously been a member of the NIE technology appraisal committee, as well as the Scottish Medicines Consortium. He is currently a member of the NIHR advanced…

Drug Shortages: What are the causes, consequences and pathways to a solution?

24 September 2024, 3:00pm

Across the globe, drug shortages are becoming increasingly common across a range of therapeutic areas. Earlier this year, OHE published a report looking at the Dynamics of Drug Shortages, and…

Chittawan Poonsiri

4 September 2024

…Her past research includes economic evaluations of medicines and medical devices to inform policy decisions in Thailand. She is now focused on research related to health equity, antimicrobial resistance, cancer,…

Challenges and Solutions for Budget Impact Analysis of Gene Therapies

10 March 2025

…to be updated to reflect the proposal. This consulting report, Challenges and Solutions for Budget Impact Analysis of Gene Therapies, was commissioned and funded by Johnson & Johnson Innovative Medicines…

Impact

…worse health outcomes for certain groups. The UK’s National Health Service (NHS) faces mounting pressures due to factors like an ageing population and rising costs of medicines and technologies. Health…